Financial LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes Shared by Ken Dropiewski on March 4, 2024 More in Financial: Elixir Medical Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025 March 18, 2025 Vektor Medical Strengthens Leadership Team to Accelerate Commercial Growth and Market Expansion March 17, 2025 Laplace Interventional Inc. Announces Series C Financing of $22M for its Transcatheter Tricuspid Valve Technology March 15, 2025 This post was originally published on this site Share this story Facebook Twitter LinkedIn LONDON–(BUSINESS WIRE)– #cardiacsurgery–LivaNova PLC announced its intention to offer $300 million aggregate principal amount of convertible senior notes due 2029 in a private offering.